ARG1 and glioblastoma: The activation of T cells in the GBM microenvironment cannot be separated from arginine, and bone marrow MSCs can produce high levels of arginase 1 (Arg1), which inhibits the activation of T cells in the microenvironment by degrading arginine degradation.